January 26, 2022
Read the latest WCM Pathology Newsletter to learn more about our Research Highlights, Scholarly Advances, new faculty and much more. You can also read our past issues here.
January 20, 2022
Dear Pathology and Laboratory Medicine Family, As you may have heard, the blood supply in New York City is at a crisis level and it is National Blood Donor Month. Due to the pandemic, and the inability to host blood drives, the New York City Blood Center currently has a 1-2 day supply. Within transfusion medicine, there are daily discussions as to the ability to supply elective surgeries with blood products. Close to 2000 donations are needed each day in the NY/NJ community for patients who require a lifesaving blood and/or platelet transfusion. In addition to using restrictive blood...
December 6, 2021
Clinical laboratories are unsung heroes of COVID-19In normal times, clinical laboratories, including pathologists, laboratory directors and clinical laboratory scientists, function in the background. We are not patient facing but provide important diagnostic tools and insights to our partner physicians and nurses. In a war analogy, we are the code breakers that support the front-line troops. Pathology is detective work, investigating the best test, understanding regulations, and figuring out the diagnosis in a timely manner. COVID-19 thrust laboratory professionals into the unknown with an...
November 17, 2021
The American Association for Cancer Research (AACR) today announced the appointment of Massimo Loda, MD, as the Editor-in-Chief of Molecular Cancer Research, one of the nine highly esteemed journals published by the AACR. Loda officially began his term on August 1.Massimo Loda, MDChairman of Pathology and Laboratory MedicineMolecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. The journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insights into pathways and processes...
November 17, 2021
Dr. C. Richard Minick (1936-2021), Professor Emeritus of Pathology and Laboratory Medicine at Weill Cornell Medicine, Cornell University, died on Long Island, New York on November 5, 2021 at the age of 85. Dr. Minick will be remembered for his extraordinary contributions to the role of cell injury and inflammation in the pathogenesis of atherosclerosis. His innovative work helped to focus scientific research on the role of immunological and viral injury in the development of cardiovascular disease. Dr. Minick published 42 substantive research papers and 19 book chapters in the field of...
September 28, 2021
Convalescent plasma did not reduce the risk of intubation or death for hospitalized COVID-19 patients in a large, international clinical trial conducted by Weill Cornell Medicine and NewYork-Presbyterian investigators in collaboration with lead investigators at McMaster University.
September 23, 2021
Turning off a defense mechanism that protects colorectal cancer tumors from being discovered by immune cells could be a possible strategy for treating the disease, according to a new study by Weill Cornell Medicine investigators. Because immunotherapy reactivates immune cells near a tumor, but fails when those cells aren’t present in significant numbers, the new approach could potentially complement this type of treatment or work on its own.
September 14, 2021
Congratulations to the dozens of WCM Pathology members who co-authored or volunteered for the new study, "More rapid, robust and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals," in The Journal of Clinical Invesitgation.
September 8, 2021
The AIDS Malignancy Consortium (AMC) Executive Committee selected our colleague Dr. Paul D. Simonson to participate in its prestigious 2021 Lab/Translational Scholar Award Program!
September 1, 2021
A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.